Pharming CEO Chouraqui steps down; names Marsh, Lynard interim co-CEOs
Bitget2026/09/29 05:00- Pharming announced CEO and executive director Fabrice Chouraqui stepped down with immediate effect.
- Chief Commercial Officer Leverne Marsh named interim co-CEO to run patient-focused operations.
- Chief Financial Officer Kenneth Lynard named interim co-CEO to oversee global corporate functions.
- Board launched a formal search for a permanent CEO successor.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
About 700,000 BTC have flowed out of exchanges in the past year.
Korean retail investors shift to the US in Q3: Sold over 5.5 trillion won of Korean stocks, purchased more than 10 trillion won of US stocks
In the third quarter, Korean retail investors made net purchases of US stocks worth approximately 10.15 trillion won, marking a complete reversal from the previous pattern in the first half of the year, when they made net purchases of nearly 100 trillion won in KOSPI stocks. In September alone, the sell-off amount reached as high as 14.2 trillion won. Analysts attribute this shift to a combination of factors: a sharp decline in KOSPI at high levels, the continued strength of the US stock market driven by AI themes, and the appreciation of the Korean won reducing currency exchange costs.
Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"
Crypto prices
More
